Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs
- 1 October 1978
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 6 (5) , 389-397
- https://doi.org/10.1007/bf01062721
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Increased methotrexate toxicity due to concurrent probenecid administrationBiochemical Pharmacology, 1976
- ALTERED PLASMA PHARMACOKINETICS OF METHOTREXATE ADMINISTERED INTRATHECALLYThe Lancet, 1975
- Neurotoxicity of Commonly Used Antineoplastic AgentsNew England Journal of Medicine, 1974
- Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1974
- Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal LeukemiaNew England Journal of Medicine, 1973
- Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target TissuesJournal of Clinical Investigation, 1973
- 5‐Hydroxyindole Acetic Acid and Homovanillic Acid in Cerebrospinal Fluid after Intrathecal and Intravenous Administration of Probenecid to Normal and Hydrocephalic DogsActa Pharmacologica et Toxicologica, 1973
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969
- Hydrocephalus: Changes in Formation and Absorption of Cerebrospinal Fluid Within the Cerebral VentriclesJournal of Neurosurgery, 1963
- Intrathecal Amethopterin in Neurological Manifestations of LeukemiaArchives of internal medicine (1960), 1958